Search

Your search keyword '"Merino, Luis"' showing total 1,604 results

Search Constraints

Start Over You searched for: Author "Merino, Luis" Remove constraint Author: "Merino, Luis"
1,604 results on '"Merino, Luis"'

Search Results

1. Adaptive Social Force Window Planner with Reinforcement Learning

2. ars548_ros. An ARS 548 RDI radar driver for ROS

3. SEOM-GEM clinical guidelines for cutaneous melanoma (2023)

4. FROG: A new people detection dataset for knee-high 2D range finders

7. HuNavSim: A ROS 2 Human Navigation Simulator for Benchmarking Human-Aware Robot Navigation

8. Impact of the valence band energy alignment at the hole-collecting interface on the photostability of wide band-gap perovskite solar cells

9. OG-SGG: Ontology-Guided Scene Graph Generation. A Case Study in Transfer Learning for Telepresence Robotics

10. Autonomous Aerial Robot for High-Speed Search and Intercept Applications

11. Technical considerations for isolated limb perfusion: A consensus paper

12. Skyeye Team at MBZIRC 2020: A team of aerial and ground robots for GPS-denied autonomous fire extinguishing in an urban building scenario

13. DLL: Direct LIDAR Localization. A map-based localization approach for aerial robots

14. Lattice decomposition of modules

15. Data Fusion of RADAR and LIDAR for Robot Localization Under Low-Visibility Conditions in Structured Environments

16. 5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAFV600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study5-Year Outcomes with Cobimetinib + Vemurafenib in Melanoma

17. Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study

21. Multi-modal Data Fusion for People Perception in the Social Robot Haru

23. Plasma mutational burden in PIK3CA and TP53 independently predicts early progression in patients with HR+/HER2- metastatic breast cancer (MBC) enrolled in the GEICAM/2014-12 FLIPPER trial.

24. Use of liquid biomarker thymidine kinase activity (TKa) to predict outcome and progression in patients with metastatic breast cancer (MBC) in the GEICAM/2014-12 FLIPPER trial.

25. On-treatment (tx) dynamic circulating tumor DNA changes (∆ctDNA) associated with progression-free survival (PFS) and overall survival (OS) of patients (pts) with HR+/HER2− advanced breast cancer (ABC) in MONALEESA-3 (ML-3).

26. Everolimus for advanced breast cancer: Is the histological subtype important?

27. Learning Human-Aware Path Planning with Fully Convolutional Networks

30. Adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma: Health-related quality of life from the randomized phase 3 KEYNOTE-716 study

32. Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial

33. Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria

35. Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial

36. Lattice embeddings between types of fuzzy sets. Closed-valued fuzzy sets

37. Enhancing social robot's direct gaze expression through vestibulo-ocular movements.

39. Design and Development of a Teleoperation System for Affective Tabletop Robot Haru

40. Developing a Robot’s Empathetic Reactive Response Inspired by a Bottom-Up Attention Model

41. An Electronic Equipment with Face Recognition Capacity Oriented to Measuring the Alcoholic Level in People

42. Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAFV600 mutation–positive melanoma

43. Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF-mutated melanoma treated in the randomized coBRIM study

45. Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study

47. Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial

49. SIAR: A Ground Robot Solution for Semi-autonomous Inspection of Visitable Sewers

50. A RGBD-Based System for Real-Time Robotic Defects Detection on Sewer Networks

Catalog

Books, media, physical & digital resources